Canada markets closed

NLS Pharmaceutics AG (NLSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6280+0.0480 (+8.28%)
At close: 03:41PM EDT
0.7000 +0.07 (+11.46%)
After hours: 07:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.32M
Enterprise Value 12.31M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)19.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.04

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-82.79%
S&P500 52-Week Change 3-2.90%
52 Week High 33.7300
52 Week Low 30.5500
50-Day Moving Average 31.1256
200-Day Moving Average 31.6794

Share Statistics

Avg Vol (3 month) 3134.68k
Avg Vol (10 day) 382.35k
Shares Outstanding 517.79M
Implied Shares Outstanding 6N/A
Float 89.74M
% Held by Insiders 128.99%
% Held by Institutions 19.23%
Shares Short (Apr 28, 2022) 4110.62k
Short Ratio (Apr 28, 2022) 42.68
Short % of Float (Apr 28, 2022) 40.90%
Short % of Shares Outstanding (Apr 28, 2022) 40.62%
Shares Short (prior month Mar 30, 2022) 4159.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-212.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.85M
Net Income Avi to Common (ttm)-11.95M
Diluted EPS (ttm)-1.0040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.43M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.38
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-14.94M
Levered Free Cash Flow (ttm)-10.66M